ATYR
aTyrDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade D from latest DB weights. Momentum 8.2 / Value 57.5
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-05.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
8
Value
57
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Earnings
2026-11-05
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-30 • Vendor: Data Vendor v1
Scores
As of 2026-10-30 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-10-30
Investment thesis
As of 2026-10-30
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-30. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $128.00
Why
Momentum8 · Δ7d -
Value57 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-05.
- • Value remains the lead driver in the composite, 7D delta +0.1.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
2026-11-05
Lead driver: Value · See fundamentals
Momentum
8
15% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
57
85% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.3
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 8.2 / Value 57.5
Fundamentals (TTM)As of 2026-10-30
Fundamentals (TTM)
As of 2026-10-30
Market Cap
$12.11M
Beta
0.60
Shares Out
2.45M
P/E (TTM) · Derived
-0.2
P/S (TTM)
384.73
P/FCF (TTM) · Derived
-8.80
Rev YoY
-100.0%
EPS YoY
-51.5%
Gross Margin
-732.6%
Op Margin
-41395.3%
Net Debt
-$66.65M
Current Ratio
5.12
As of 2026-10-30 • Updated nightlySource: Internal modelMethods & Data